Cargando…

Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus

Type 1 diabetes is caused by autoreactive T cells that destroy pancreatic beta cells. Animal models suggested that a CD4(+)CD25(+) population has a regulatory function capable of preventing activation and effector functions of autoreactive T cells. However, the role of CD4(+)CD25(high) T cells in au...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perri, Valentina, Russo, Benedetta, Crinò, Antonino, Schiaffini, Riccardo, Giorda, Ezio, Cappa, Marco, Rosado, Maria Manuela, Fierabracci, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613325/ https://www.ncbi.nlm.nih.gov/pubmed/26393578 http://dx.doi.org/10.3390/ijms160922584

Ejemplares similares

Altered B Cell Homeostasis and Toll-Like Receptor 9-Driven Response in Type 1 Diabetes Carriers of the C1858T PTPN22 Allelic Variant: Implications in the Disease Pathogenesis
por: Gianchecchi, Elena, et al.
Publicado: (2014)

Identification and functional characterization of CD8(+) T regulatory cells in type 1 diabetes patients
por: Pellegrino, Marsha, et al.
Publicado: (2019)

Identification of GAD65 AA 114-122 reactive 'memory-like' NK cells in newly diagnosed Type 1 diabetic patients by HLA-class I pentamers
por: Perri, Valentina, et al.
Publicado: (2017)

SARS-CoV-2 infection as possible downstream disease precipitator in autoantibody-positive insulin-dependent diabetes mellitus: a case report
por: Schiaffini, Riccardo, et al.
Publicado: (2022)

p53 Activation Effect in the Balance of T Regulatory and Effector Cell Subsets in Patients With Thyroid Cancer and Autoimmunity
por: Arena, Andrea, et al.
Publicado: (2021)

Preparation and In Vitro Evaluation of RITUXfab-Decorated Lipoplexes to Improve Delivery of siRNA Targeting C1858T PTPN22 Variant in B Lymphocytes
por: Arena, Andrea, et al.
Publicado: (2021)

Endocrine autoimmunity in Turner syndrome
por: Grossi, Armando, et al.
Publicado: (2013)

Immunotherapy Strategies for the Prevention and Treatment of Distinct Stages of Type 1 Diabetes: An Overview
por: Rapini, Novella, et al.
Publicado: (2020)

Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity
por: Arena, Andrea, et al.
Publicado: (2022)

Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients
por: Pellegrino, Marsha, et al.
Publicado: (2020)

Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression
por: Gianchecchi, Elena, et al.
Publicado: (2018)

A rare occurrence of non-classic congenital adrenal hyperplasia and type 1 diabetes mellitus in a girl with Prader-Willi Syndrome: Case report and review of the literature
por: Aureli, Alessia, et al.
Publicado: (2023)

Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes
por: Perri, Valentina, et al.
Publicado: (2017)

Detection of GAD65 Autoreactive T-Cells by HLA Class I Tetramers in Type 1 Diabetic Patients
por: Giuliani, Laura, et al.
Publicado: (2009)

Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression
por: Zhang, Yun-Qiang, et al.
Publicado: (2021)

B Lymphocytes Are Predictors of Insulin Resistance in Women with  Gestational Diabetes Mellitus
por: Zhuang, Yan, et al.
Publicado: (2019)

Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity
por: Gianchecchi, Elena, et al.
Publicado: (2020)

Diabetes and prediabetes in children with cystic fibrosis
por: Schiaffini, Riccardo, et al.
Publicado: (2023)

Regulatory T Lymphocytes
por: Frank, David A.
Publicado: (1981)

Upregulation of Galectin-9 and PD-L1 Immune Checkpoints Molecules in Patients with Chronic Lymphocytic Leukemia
por: Taghiloo, Saeid, et al.
Publicado: (2017)

Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines
Publicado: (1979)

Clinical Significance of Negative Costimulatory Molecule PD-1/PD-L1 on Peripheral Blood Regulatory T Cell Levels among Patients with Pulmonary Tuberculosis
por: Yang, Chenchen, et al.
Publicado: (2022)

Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia
por: d'Annunzio, Giuseppe, et al.
Publicado: (2020)

The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis
por: Neumann, Katrin, et al.
Publicado: (2019)

Overexpression of PD-1-related molecules is associated with lymphocyte anergy, mortality, and development of nosocomial infections in septic shock patients
por: Guignant, C, et al.
Publicado: (2010)

A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
por: Candido, Riccardo, et al.
Publicado: (2018)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients
por: Lou, Meiqin, et al.
Publicado: (2015)

Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus
por: Arneth, Borros
Publicado: (2017)

The Role of the Immune Checkpoint Molecules PD-1/PD-L1 and TIM-3/Gal-9 in the Pathogenesis of Preeclampsia—A Narrative Review
por: Mittelberger, Johanna, et al.
Publicado: (2022)

A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes
por: Scaramuzza, Andrea E., et al.
Publicado: (2022)

Flavonoids and Insulin-Resistance: From Molecular Evidences to Clinical Trials
por: Russo, Benedetta, et al.
Publicado: (2019)

Resistant Hypertension, Time‐Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus
por: Viazzi, Francesca, et al.
Publicado: (2017)

Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line
Publicado: (1980)

PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma
por: Cao, Jinfeng, et al.
Publicado: (2017)

Editorial: Diabetic ketoacidosis in children and adolescents: From epidemiological data to clinical aspects
por: Zucchini, Stefano, et al.
Publicado: (2023)

High‐affinity PD‐1 molecules deliver improved interaction with PD‐L1 and PD‐L2
por: Li, Yanyan, et al.
Publicado: (2018)

The Insulin Treatment of Diabetes Mellitus
Publicado: (1924)

Pancreatic Insulin in Diabetes Mellitus
por: Turtle, John R.
Publicado: (1971)

Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor?
por: Dolcetti, Riccardo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_71ppkvcod41uk5gnrlri21oqah